000 01465 a2200445 4500
005 20250518015826.0
264 0 _c20191129
008 201911s 0 0 eng d
022 _a1545-5017
024 7 _a10.1002/pbc.27571
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDilly-Feldis, Marie
245 0 0 _aExpression of PD-1/PD-L1 in children's classical Hodgkin lymphomas.
_h[electronic resource]
260 _bPediatric blood & cancer
_c05 2019
300 _ae27571 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAntineoplastic Agents, Immunological
_xtherapeutic use
650 0 4 _aB7-H1 Antigen
_xmetabolism
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aDrug Resistance, Neoplasm
_xdrug effects
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHodgkin Disease
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aMale
650 0 4 _aNeoplasm Recurrence, Local
_xdrug therapy
650 0 4 _aPrognosis
650 0 4 _aProgrammed Cell Death 1 Receptor
_xmetabolism
650 0 4 _aRemission Induction
700 1 _aAladjidi, Nathalie
700 1 _aRefait, John K
700 1 _aParrens, Marie
700 1 _aDucassou, Stéphane
700 1 _aRullier, Anne
773 0 _tPediatric blood & cancer
_gvol. 66
_gno. 5
_gp. e27571
856 4 0 _uhttps://doi.org/10.1002/pbc.27571
_zAvailable from publisher's website
999 _c29249043
_d29249043